Eagle Bay Advisors’s Zymergen Inc. Common Stock ZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-159
Closed -$1K 1035
2022
Q3
$1K Hold
159
﹤0.01% 897
2022
Q2
$196 Buy
+159
New +$267 ﹤0.01% 1066
2022
Q1
Sell
-159
Closed -$1K 1050
2021
Q4
$1K Hold
159
﹤0.01% 1087
2021
Q3
$2K Hold
159
﹤0.01% 1016
2021
Q2
$7K Buy
+159
New +$6.28K 0.01% 722

Eagle Bay Advisors's ZY Position: Q4 2022 in Review

Eagle Bay Advisors sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 159 shares — an estimated $1K sold.

Eagle Bay Advisors first reported a position in ZY in Q2 2021 and held it in 5 quarters. The position peaked at $7K in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • Eagle Bay Advisors reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Eagle Bay Advisors sold 159 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $1K.
  • Eagle Bay Advisors first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • Eagle Bay Advisors's Zymergen Inc. Common Stock position peaked at $7K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Eagle Bay Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.